SCHEMBL6861577

SCHEMBL6861577

COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\c2ccccn2)ccc1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 19/20 0.69
CHEK2 O96017 3/20 0.69
CDK1 P06493 2/20 0.69
SGK1 O00141 1/20 0.69
TEK Q02763 1/20 0.69
SRC P12931 1/20 0.67
CSNK2A2 P19784 1/20 0.67
CSNK2B P67870 1/20 0.67
CSNK2A1 P68400 1/20 0.67
TUBB4A P04350 1/20 0.66
TUBB P07437 1/20 0.66
TUBA3C P0DPH7 1/20 0.66
TUBA1B P68363 1/20 0.66
TUBA4A P68366 1/20 0.66
TUBB4B P68371 1/20 0.66
TUBB3 Q13509 1/20 0.66
TUBB2A Q13885 1/20 0.66
TUBB8 Q3ZCM7 1/20 0.66
TUBA3E Q6PEY2 1/20 0.66
TUBA1A Q71U36 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6860670 1.00 CHEK1 (0.69) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL6646612 1.00 CHEK1 (0.69) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL6863002 0.80 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL6862997 0.80 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL6671445 0.80 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL6671453 0.80 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL6674605 0.79 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL31061315 0.79 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL6674608 0.79 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK
SCHEMBL4013531 0.78 CHEK1 (1.00) CHEK1CHEK2CDK1SGK1TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6797825-B2 1,3-DIHYDRO-2H-INDOL- 2-ONE DERIVATIVES ABBOTT LABORATORIES 2004-09-28 US disclosed
US-20030162785-A1 Protein kinase inhibitors ABBVIE INC. 2003-08-28 US disclosed
US-20030119839-A1 Protein kinase inhibitors ABBOTT LABORATORIES 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162785-A1 Protein kinase inhibitors MAP3K20, MAP3K1, MAP3K6 CHEK1 139/4885CHEK2 93/4885CDK1 62/4885
US-20030119839-A1 Protein kinase inhibitors MAP3K20, MAP3K1, MAP3K6 CHEK1 139/4885CHEK2 93/4885CDK1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.